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2 
Abstract 26 
The aim of the study was to evaluate the effect of systematic agitation, increasing ionic 27 
strength and gel strength on drug release from a gel-forming matrix (HPMC E10M, E4M and 28 
E50LV) using USP type III Bio-Dis apparatus with theophylline as a model drug. The 29 
triboelectric charging; particle sizing, water content, true density and SEM of all the 30 
hypromellose grades, theophylline and formulated blends were characterised.  The results 31 
showed that balanced inter-particulate forces exist between drug particles and the excipient 32 
surface and this enabled optimum charge to mass ratio to be measured. Agitation and ionic 33 
strength affected drug release from E50LV and E4M tablet matrices in comparison to the 34 
E10M tablet matrices. Drug release increased substantially when water was used as the 35 
dissolution media relative to media at pH 1.2 (containing 0.4 M NaCl). The results showed all 36 
f2 values for the E10M tablet matrices were above 50 suggesting the drug release from these 37 
tablet matrices to be similar. Rheological data also explained the different drug release 38 
behaviour with the stress required to yield/erode being 1 Pa, 150 Pa, and 320 Pa, for the 39 
E50LV, E4M and E10M respectively. The stiffness of the gel was also found to be varied 40 
from 2.5 Pa, 176.2 Pa and 408.3 Pa for the E50 LV, E4M and E10M respectively. The lower 41 
G’ value can be explained by a softer gel being formed after tablet introduction into the 42 
dissolution media thereby indicating faster drug release.  43 
 44 
 45 
 46 
 47 
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1. Introduction 50 
Polymer based matrix systems are popular in controlled release formulations in terms of 51 
economic, process development and scale up procedures [1-5].  Polymer-based matrix tablets 52 
swell once in contact with fluid, forming a gel-layer, which controls drug release from the 53 
formulation. The release of drug from the swollen gel matrix depends on the possible 54 
interactions between the aqueous dissolution medium, polymer, drug and other tablet 55 
ingredients [6-8]. An important factor that affects bioavailability of drugs is the presence of 56 
food due to potential interactions that may occur between the formulation and the food [9, 10] 57 
such as chelation of penicillamine by iron in the gut leading to reduction in its absorption and 58 
activity. Furthermore, the physiological response to ingestion of food such as gastric acid 59 
secretion may increase of decrease the bioavailability of some drugs [11-13]. pH and ionic 60 
strength of the gastrointestinal (GI) fluids  vary greatly along the GI tract under both fasted  61 
and fed conditions [14, 15] and this can affect the rate at which a drug is released from 62 
hydrophilic extended release (ER) matrices [16-20]. The gel layer formed around hydrophilic 63 
matrices, upon its contact with GI fluids, is eroded allowing drug release. Erosion is the 64 
dominant release mechanism for poorly soluble drugs, whereas the soluble portion of drug is 65 
released by diffusion through the gel layer [9, 10, 21-23]. Due to the non-ionic nature of 66 
hydroxypropyl methylcellulose (HPMC), when drug solubility is pH- independent, the 67 
matrices also exhibit pH-independent drug releases profiles [24]. The high molecular weight 68 
chemistries are the most widely used polymers in ER matrix formulations, e.g., 69 
METHOCEL
TM
 Premium K (hypromellose 2208, USP) and E (hypromellose 2910, USP). 70 
The HPMC substitution type and molecular weight has an effect on the amount of water 71 
bound to the polymer [25]. According to Aoki and co-workers [26], during the initial stage of 72 
dissolution, water penetrates into the matrix and usually acts as non-freezing (bound) water. 73 
In the next stage, the water content of the matrix increases and freezable water is detected at 74 
 
4 
levels that are related to drug release. They also reported that the transport of solutes mainly 75 
occurs through the free water and that only little transport occurs through bound water. 76 
Yoshioka and coworkers [27], studied hydrophilic polymeric gelatin gels and claimed that 77 
bound water did not participate to any significant effect in the hydration process and that the 78 
hydrolysis/water-uptake rate depended mainly on the amount of free water present in the 79 
system. Therefore, determining the dynamics and state of water molecules in hydrogels 80 
enables a better understanding of the swelling process of the hydrophilic matrices and the 81 
release of drugs from these systems [28].  Three types of hydration water has been reported  82 
[29] with each possessing different physical properties; Type I (freezing or free, bulk-like 83 
water) melts at the normal melting point of pure water (0 
o
C); Type II (freezing or bound 84 
water) interacts weakly with macromolecules and displays a lower melting point than pure 85 
water (< 0 
o
C) and Type III (bound water) which interacts strongly with hydrophilic and ionic 86 
groups of the polymer and shows non-freezing behaviour.  87 
Pharmaceutical powders are prone to electrostatic charging because they normally have a 88 
high electrical resistance, preventing charge dissipation. Triboelectrification is a phenomenon 89 
which refers to electrostatic charge being generated due to the difference in electrical 90 
potential when two materials come into contact with each other. The ability to control the 91 
charging of pharmaceutical powders is essential in improving the quality of the end product 92 
and minimising powder loss. Triboelectrification is used to help with the mixing operations in 93 
industry [30, 31] More recently, the triboelectric charging behaviour of E4M, K4M and their 94 
powder blends with theophylline, were studied. It was shown that when theophylline was 95 
mixed with hypromellose grades of opposite polarities, the triboelectric charge of the final 96 
powder mixture was decreased forming a stable ordered mixture believed to result in a more 97 
homogenous and stable system [32].    98 
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In the present work, three grades of the E chemistry HPMC polymer, and their formulated 99 
blends were characterised by triboelectrification, particle sizing and particle morphology. 100 
Theophylline release from these polymers were assessed with varying  agitation sequences, 101 
ionic strengths and pH levels using the USP III apparatus to discriminate between the 102 
performances of the polymers. This study was performed with a view to differentiate between 103 
poor and robust sustained release formulations. Rheological experiments were also conducted 104 
to ascertain the influence of the various ionic strengths on the gel layer produced form these 105 
polymers.   106 
 107 
2. Materials and methods 108 
2.1. Materials 109 
HPMC E chemistry grades METHOCEL™, E50LV, E4M and E10M supplied by Colorcon 110 
UK were used as the hydrophilic matrix formers. Anhydrous theophylline was obtained from 111 
Sigma, UK. Dissolution buffers were prepared according to the USP 2003 [33] using the 112 
following materials: potassium chloride (Acros Organics, UK) and hydrochloric acid (Fisher 113 
Scientific, UK) for dissolution media at pH 1.2 and pH 2.2;  potassium phosphate monobasic- 114 
(Fisher BioReagents, UK) and sodium hydroxide (Fisher Scientific, UK) for dissolution 115 
media at pH 5.8, 6.8, 7.2 and 7.5 . 116 
 117 
2.2. Powder characterisation  118 
2.2.1. Electrostatic properties of pure polymers and formulated blends 119 
A triboelectric device based on a shaking concept, previously described by Šupuk and co-120 
workers [34-36] was used to investigate the triboelectrification of theophylline, the three 121 
HPMC E chemistry polymers and their formulation blends (the formulation blends were in 122 
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the ratio of 4:1 (drug: HPMC) for 10 min at 100 rpm in a Turbula
® 
mixer. This is further 123 
detailed in section 2.6) by determining the charge-to-mass ratio. In this work, the charge-to-124 
mass ratio of the bulk powders was measured after shaking using a custom-made Faraday cup 125 
connected to an electrometer (Keithley Model 6514). If a positively-charged particle enters 126 
the Faraday cup, a negative charge is induced and distributed on the inner surface of the 127 
Faraday cup, whilst a positive charge is distributed over the outer surface of the cup, setting 128 
up an electric field and a potential difference between the two cups. The capacitance C 129 
between the inner and outer cups acquires a potential, � = �/� which is measured by an 130 
electrometer connected to an inner cup.  The charge-to-mass ratio is obtained by dividing the 131 
net charge measured and the mass of the sample tested. Tests were carried out under ambient 132 
temperature (22 ºC) and humidity (35 - 47 %RH).  133 
 134 
2.3. Micromeritic properties of polymers  135 
2.3.1. Particle size analysis  136 
Particle size distribution (PSD) analysis was conducted on an aerosolised dry samples of the 137 
HPMC E50LV, E4M and E10M using a Sympatec (Clausthal-Zellerfeld, Germany) laser 138 
diffraction particle size analyser as described previously [37].  139 
 140 
2.3.2. True density measurements 141 
The Ultrapycnometer 100 (Quantachrome Instruments) was used in the determination of the 142 
true density of powder mixtures used for the tableting. The test was carried out using a multi-143 
run system with a standard deviation of 0.005 %. The results presented are the mean and 144 
standard deviation of a minimum of three determinations.  145 
 146 
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2.3.3. Surface area measurements 147 
Brunauer–Emmett–Teller (BET) surface area was measured by nitrogen adsorption using 148 
Micromeritics Gemini 6 (Norcross, USA) automated gas sorption system model. The 149 
determination of external surface area was estimated by using the standard t-plot calculations 150 
by using experimental points at a relative pressure of P/P0 = 0.1 - 0.5. All measurements 151 
were done in triplicate. Surface roughness of different polymers tested was calculated based 152 
on the ratio between BET surface area and theoretical surface area [37]  153 
 154 
2.3.4. Water content analysis 155 
The moisture content of the samples was determined semi-automatically by the Karl Fisher 156 
method (Metter Toledo, C20 Coulometric KF Titrator, Switzerland). The Fischer reagent 157 
solution was Hydranal
®
 Coulomat AF (Sigma Aldrich, USA). 158 
 159 
2.4. Scanning electron microscopy (SEM) 160 
Electron micrographs of all polymers were obtained using a scanning electron microscope 161 
(SEM) (Philips XL 20, Eindhoven, Netherlands) operating at either 2 or 5 kV. The samples 162 
were mounted on a metal stub with double-sided adhesive tape and coated under vacuum 163 
with gold in an argon atmosphere prior to observation. Several magnifications (x100 -3000 164 
magnifications) were used to observe the shape and surface topography of particles of the 165 
different HPMC grades.  166 
 167 
2.5. Rheological measurements 168 
2.5.1 Sample preparation of rheological study 169 
Two sets of samples were prepared from E50V, E4M and E10M HPMC polymers to make 5 170 
% w/v into pH 1.2 media (no NaCl) and pH 1.2 media (0.4M NaCl) at 37  ± 0.5 °C. The 171 
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samples were then subjected to rheological measurements to investigate their stiffness and the 172 
strength of the gel after the swelling process in the media.  All rheological measurements 173 
were performed using a Bohlin Gemini Nano HR rheometer (Malvern Instruments, 174 
Worcestershire, UK) fitted with 55 mm parallel-plate geometry. 175 
 176 
2.5.2. Yield stress determination 177 
Stress sweep rheological studies were used to determine yield stress of different gel 178 
formulations to predict the stress required to initiate erosion. The stress was gradually 179 
increased from 0.1 Pa to 1000 Pa at 1.5 rad s
−1
 angular frequency. All measurements were 180 
taken at 37 ± 0.5 °C. 181 
 182 
2.5.3. Frequency Sweep measurement 183 
The rheological behaviour of the samples was evaluated in terms of the elastic (storage) 184 
modulus (Gƍ) and the viscous (loss) modulus (GƎ) as a function of angular frequency (0.1–185 
100 rad s
−1
 angular frequency) to produce mechanical spectra of the samples. Measurements 186 
were taken at 37 ± 0.5 °C and performed at 0.5 % strain (strain amplitude chosen was within 187 
the linear viscoelastic region of the sample). 188 
 189 
2.5.4. Single frequency measurement 190 
Oscillation mode (single frequency –stress control) was used to determine the viscoelasticity 191 
of the gel formed after swelling. In order to understand how the elastic modus (Gƍ) of the gel 192 
was affected by the different HPMC grades, a 5 %w/v of each of the E chemistry HPMC 193 
grades was dispersed in media at pH 1.2 at 37 ± 0.5 °C and left to hydrate for 1 h before 194 
rheological measurements were obtained. 195 
 
9 
The measurements were recorded at 1.5 rad s
−1
 angular frequency and 0.5 % strain with a 196 
0.6 mm gap. The strain amplitude chosen was within the linear viscoelastic region of the 197 
samples. All measurements were taken at 37 ± 0.5 °C. 198 
 199 
2.6. Tablet preparation and mechanical strength test 200 
Round cylindrical tablets with a diameter of 9.6 ± 0.1 mm and the target weight of 250 ± 1 201 
mg were prepared by blending theophylline with HPMC E50LV, E4M or E10M in the ratio 202 
of 4:1 for 10 min at 100 rpm in a Turbula
® 
mixer (Type T2 C, Switzerland). The tablets were 203 
compressed using a single punch-tableting machine (Model MTCM-1, Globe Pharma, US) at 204 
1500 psi (5.55 kN). The die wall was lubricated each time after tablet compression with a 1 205 
% w/v suspension of magnesium stearate (Acrõs Organics, New Jersey, USA) in acetone 206 
(Fisher Scientific, UK). The breaking force for five tablets was determined using Schleuniger 207 
8M tester (Switzerland). .  208 
 209 
2.7. Dissolution test 210 
2.7.1. Effect of pH and agitation 211 
Drug release profile of the formulations was investigated in six different dissolution media to 212 
evaluate the degree of sensitivity of the different methoxyl substitution grades of HPMC to 213 
pH. A series of buffer solutions that simulated the stomach and intestinal conditions in fasted 214 
and fed states with the pH values of 1.2, 2.2, 5.8, 6.8, 7.2 and 7.5 were used. The dissolution 215 
testing was conducted for 310 min for all formulations. The influence of agitation on drug 216 
release was studied and  detailed in a previous study  [38]. All theophylline-HPMC (E50LV, 217 
E4M and E10M) formulations were tested using this developed methodology and it 218 
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facilitated the discrimination of the effect of agitation on the formulations where different 219 
viscosity or molecular weight grades of the HPMC were used.  220 
 221 
2.7.2. Influence of ionic strength 222 
Sodium chloride was used to regulate the ionic strengths of the media from 0 to 0.4 M in 223 
buffers with pH values of 1.2, 2.2, 5.8, 6.8, 7.2 and 7.5. The ionic strength of the fluids of the 224 
GI tract in man under both fasted and fed states and various physiological pH conditions 225 
cover a range of 0 - 0.4 M [39]. Sodium chloride is the mid-range of the lyotropic series and 226 
has the ability to salt out polymers, hence is often used as the agent for ionic regulation of 227 
dissolution media [39, 40]. Both theophylline E50LV, E4M and E10M formulations were 228 
tested by varying  ionic strength of the dissolution media as reported by Asare-Addo et al. 229 
[41]. The absorbance of the released theophylline was measured at 271 nm using a 230 
UV/Visible spectrophotometer (Varian, Cary 50). 231 
 232 
2.8. Similarity factor 233 
Similarity factor was calculated as detailed in Asare-Addo et al. [38, 42] for the effect of 234 
agitation. Drug release in water was used in the determination of f2 values where ionic 235 
strength was concerned as detailed in Asare-Addo et al., [41] f2 values above 50 is an 236 
indication of similarity, while  less than 50 indicates dissimilarity between two dissolution 237 
profiles [43].  238 
 239 
2.9. Dissolution parameters 240 
The mean dissolution time (MDT), which is the mean time for the drug to dissolve under in-241 
vitro dissolution conditions, is a model-independent method and is suitable for dosage forms 242 
that exhibit  different mechanisms of drug release [39, 44]. As this study uses different 243 
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viscosities of HPMC polymers, it provides a way of comparing the dissolution profiles. The 244 
dissolution efficiency (DE) and mean dissolution rates (MDR) were also calculated. The 245 
equations for the calculation of these dissolution parameters are detailed elsewhere [45].  246 
 247 
2.10. Kinetics of drug release  248 
The kinetics of drug release was analysed using Peppas equation [46] as detailed in a 249 
previous study  [38]. In general for drug release from films [46], n values close to 0.5 are 250 
indicative of the drug release being primarily by diffusion. Values of n = 1 gives an 251 
indication that drug is released by relaxation and erosion processes. Anomalous transport is 252 
the term given to n values between 0.5 and 1. This is an indicator of the superposition of both 253 
processes. However, for the tablet matrices which are cylindrical in shape, the n values are 254 
slightly different as derived by [46] Values of n of up to 0.45 suggest Fickian diffusion, and 255 
values above 0.89 suggest Case-II transport. Values between these two suggest the 256 
occurrence of anomalous transport.  257 
 258 
2.11. Differential Scanning Calorimetry (DSC) 259 
Part A:  260 
Samples of physical mixtures of drug and polymer after the mixing process in section 2.6 261 
were placed in standard 40 µL aluminium crucibles and sealed.  The aluminum pans were 262 
heated (from 25 
o
C to 300 
o
C at 10 
o
C/min under nitrogen gas) to examine potential drug 263 
interactions.  264 
Part B:  265 
Flat-faced 4 mm disks with target weights of 20 mg each were produced from all four 266 
theophylline-HPMC (E50LV, E4M and E10M) mixtures and compressed using a single 267 
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punch tableting machine (Model MTCM-1, Globe Pharma, US) at 1500 psi (5.55 kN). The 268 
die wall was lubricated each time after tablet compression with a 1 % w/v suspension of 269 
magnesium stearate in acetone. The discs were hydrated for 5, 10, 15 and 20 min using 270 
purified water, pH 1.2, pH 1.2 (0.2 M ionic strength) and pH 1.2 (0.4 M ionic strength), 271 
placed in standard aluminium pans and sealed with a lid. The aluminium pans were firstly 272 
cooled from ambient temperatures (~25 
o
C) to -30 
o
C at 55 
o
C/min, to freeze any unbound 273 
(free) water; maintained at -30 
o
C for 5 minutes for equilibration and then heated from -30 
o
C 274 
to 50 
o
C at 10 
o
C/min under nitrogen gas to determine amount of free and bound water and 275 
hydration rate of the tablets using endothermic scanning of the melted free water [41, 47].  276 
These experiments were carried out in triplicate. 277 
 278 
3. Results and discussion 279 
3.1. HPMC polymer and formulation characterization 280 
Triboelectrification experiments were performed to evaluate charging and adhesion 281 
behaviour of theophylline on addition of different HPMC polymers. The charge test for 282 
theophylline on its own indicated that the saturated charge is –23nC/g after shaking for two 283 
minutes (Table 1). The level of charge is relatively low compared to common API charge as 284 
reported previously [48]. Triboelectrification of polymers shows E4M to be charged 285 
positively against the stainless steel container, whilst E10M and E50LV both had slight 286 
electronegative charges. The magnitude of charge of E4M was notably higher than E10M and 287 
E50LV. In general, it was shown that the negative charge of theophylline decreased after 288 
blending with HPMC polymers. Theophylline charged negatively as did the blends, but the 289 
magnitude was reduced due to the presence of HPMC polymer in the blends. The charge 290 
generated by a material depends entirely on contact between surfaces. Generally, particulates 291 
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that are fine tend to charge negatively. Larger particles on the other hand tend to charge 292 
positively. A hypothetical mechanism for particle size dependent charging was provided by 293 
Lacks and Levandovsky, [49]. It has been argued that collisions allow electrons trapped in 294 
high-energy states on one particle to transfer to the vacant low-energy states on another 295 
particle assuming that the surface density of trapped electrons is initially the same on all 296 
particles [50, 51]. Therefore, as HPMC polymer is blended with theophylline, the charge that 297 
is measured is mainly that of the polymer despite the drug being in excess (by weight). All 298 
powder blends had similar adhesion to the walls of the vessel, irrespective of the chemistry or 299 
molecular weight of the polymer (p > 0.05).  300 
E chemistry polymers demonstrated different physical properties as summarized in Table 1. 301 
The mean diameter ranged between 72.7 ± 0.2 and 81.9 ± 0.3 µm, which was further 302 
qualitatively confirmed by SEM images (Supplementary figure 1).  E4M had the largest 303 
particle size with the narrowest size distribution (as indicated by the smallest span), the 304 
highest specific surface area and the roughest surface texture. On the other hand, E50LV 305 
showed the smallest size with widest size distribution, the smallest specific surface area and 306 
the smoothest surface texture among polymers tested (Table 1). The E chemistry polymers 307 
also had a water content range between 3.4 and 3.7 %w/w. The E chemistry 4:1 drug:HPMC 308 
formulations showed that they are robust formulations in terms of tablet hardness (50-76 kN). 309 
The rank order breaking force or mechanical strength of the E chemistry HPMC tablet 310 
matrices was E10M > E50LV > E4M. 311 
3.2. Effect of agitation 312 
Figure 1a shows the influence of agitation rate and sequence on drug release from tablets that 313 
contain the E chemistry HPMC grades. For matrices containing the low viscosity polymer 314 
E50LV, once in water with the applied agitation, fragments of the tablet were detaching from 315 
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the matrix surface into the solution before a full gelatinous layer was formed, although none 316 
of the tablets actually disintegrated. Drug release increased with an increase in the agitation 317 
rate. Drug release rate was in the order of E50LV > E4M > E10M (For E4M and E10M, refer 318 
to Supplementary figure 2). This showed that the erosion occurring because of the increased 319 
agitation rate was more rapid for the HPMC with the lower molecular weight, which in this 320 
case was the E50LV. This could be explained as follows; The gel being formed on the 321 
surface of the tablet upon its introduction into media could limit the amount of drug being 322 
transported into the solution as drug moved from one medium condition to another and the 323 
change in the tablets geometry as a result of agitation meaning a decreased surface area for 324 
the next medium. The E10M tablet matrices however as compared to the E4M and E50LV 325 
tablet matrices was less prone to the effects of agitation due to its high elasticity G’ hence, 326 
higher stress required to yield (Figure 5) [38]. 327 
A comparison of the two different agitations rates in the ascending order of 5-30 dpm and 328 
descending order of 30-5 dpm confirmed the susceptibility of the E50LV tablet matrices to 329 
the effects of agitation. All drug was released in pH 2.2 medium after just 120 min in the 330 
descending form of agitation (30-5 dpm) (Figure 2a). In the case of E4M matrices, the entire 331 
drug was released in pH 7.2 medium after 280 min with a starting agitation of 30 dpm, with 332 
75 % of the drug released in pH 1.2 alone. When agitation was started at 5 dpm, 76 % of the 333 
drug was released after 310 min in pH 7.5 (Supplementary figure 3). The E10M showed 334 
resilience after the dissolution process of 310 min with a drug release of 77 % in the 335 
ascending order of agitation (5-30 dpm) and 89 % in the descending order (30-5 dpm) in pH 336 
7.5 (Figure 2b). These results show that drug release can vary at different pHs for non-ioinc 337 
polymers depending on the agitation rate and molecular weight of polymers. For example, for 338 
formulations that are not robust, the agitation could cause a relatively fast drug release 339 
resulting in a possible toxicity or making a drug unavailable at the targeted site [32, 52] . The 340 
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generally fast rate of drug release from the tablet matrices rendered most of the dissolution 341 
profiles dissimilar or impossible to calculate (Table 2). Anomalous transport was the only 342 
mechanism of drug release from the E50LV tablet matrices (Table 2). The E4M and E10M 343 
tablet matrices on the other hand were dominated by Fickian diffusion with anomalous 344 
transport occurring over the increasing order of agitation (5-30 dpm) with respective values 345 
of 0.50 and 0.47 (Table 2). 346 
3.3. Effect of ionic strength 347 
Figure 3 a and supplementary figures 4 a and b shows the impact of ionic strength on drug 348 
release from E50LV, E4M and E10M tablet matrices respectively with supplementary figure 349 
5 showing the drug release rates. The ionic strength of buffers used to control pH varied from 350 
0.05-0.14 M. The addition of 0.2 M and 0.4 M sodium chloride means the actual ionic 351 
concentration strength at the 0.2 M level ranged between 0.25-0.34 M and for the 0.4 M 352 
ranged between 0.45-0.54 M but for consistency, the ionic strength of the added NaCl is used 353 
in legends.  354 
Similarity calculations were not valid for release of theophylline from the E50LV (Table 3). 355 
This was a result of the quick drug release from its matrices thereby not having enough time 356 
points for a valid analysis. With regards to the E4M tablet matrices, similarity was only 357 
obtained in the pH media with an f2 value of 95. The E10M tablet matrix was the most robust 358 
of the formulations. Despite the fall in the f2 parameter as ionic strength increased, release 359 
profiles were similar at different ionic strengths with f2 values of 63 and 50 in pH-controlled 360 
media of ionic strengths 0.2 and 0.4 M respectively (Table 3). At pH 1.2 only, drug release 361 
from E50LV tablet matrices increased after 1 hour from 64.76 + 0.79 % in deionised water to 362 
76.14 + 1.86 % when ionic strength was increased to 0.4 M. 66.51 + 2.66 % and 65.87 + 2.24 363 
% of drug had been released from the tablet matrices for the E4M formulation in deionised 364 
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water or pH1.2 medium without added salt (Figure 3b). Upon 0.2 and 0.4 M NaCl, drug 365 
release from tablet matrices increased to 83.65 + 7.48 % and 83.08 + 5.02 % respectively. 366 
This significant increase was not reproduced for drug release from the E10M tablet. 50.72 + 367 
5.58 % of drug was released in deionised water, increasing to 56.42 + 4.01 % on addition of 368 
0.2 M NaCl and a further increase occurred with 0.4 M NaCl (Figure 3b). At the low ionic 369 
strengths (buffers with no added salt), the polymer hydration seems to be unaffected. Higher 370 
ionic strengths however may have led to a loss of gel integrity of the E50LV and E4M 371 
matrices hence the increase and difference in their drug release profiles. The E10M was thus 372 
more resilient to the influence of ionic strength in comparison to the E50LV and E4M 373 
formulations due to its increased viscosity. The results show that despite HPMC being a non-374 
ionic polymer, the medium ionic composition can influence its behaviour drug release 375 
behaviour. This was in agreement with work done by Kavanagh and Corrigan [53]. They 376 
showed that an increase in ionic strength brought about a decrease in matrix erosion rate with 377 
the phenomenon being prevalent in low molecular weight HPMC grades. Alderman [54] also 378 
noted that as the ionic strength of the medium increases, the polymer molecular chains loose 379 
water of hydration due to ions competing for the available water. 380 
MDTs generally decreased with increasing ionic strength for all matrices. The E50LV tablet 381 
matrix exhibited anomalous transport in deionised water and buffers, with Fickian kinetics 382 
becoming more dominant with increasing ionic strength (Table 3). Fickian release dominated 383 
for all E4M and E10M formulations.  384 
3.4 Evaluation of gel strength of HPMC polymer 385 
It has been observed that the different HPMC grades show different drug release behaviour. 386 
In order to clarify these findings, the rheological properties of the polymers used were 387 
determined by oscillatory rheometry. The stiffness and degree of inter-particle interaction 388 
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were evaluated by stress sweep rheological measurements. Figure 4a shows the yield stress 389 
and gel strength for different HPMC grades. The yield stress can be inferred from the stress at 390 
which G’ starts to decrease. The stress required to yield or to erode were 1 Pa, 150 Pa, and 391 
320 Pa, for the E50 LV, E4M and E10M respectively. This result indicates a high degree of 392 
inter-particle interactions which suggests a lower degree of erosion for E10M [55, 56]. The 393 
stiffness of the gel was also found to be varied from 2.5 Pa, 176.2 Pa and 408.3 Pa for the 394 
E50LV, E4M and E10M respectively. The lower G’ value can be explained by a softer gel 395 
being formed after tablet introduction into the dissolution media. The reduction in stiffness of 396 
the gel indicates faster drug release [57]. Figure 4b and supplementary figure 6a and b shows 397 
elastic modulus G’ and viscous modulus G’’ versus frequency sweep oscillation for E50LV, 398 
E4M and E10M. E50LV, E4M and E10M exhibit similar classical temporary network 399 
response with G” Greater than G’ at low frequencies, indicating that the polymer behaves as a 400 
viscous liquid. By increasing the frequency G’ increased and G’’ decreased gradually until 401 
they crossed over at the critical gel point frequency (indicated by black arrow). At higher 402 
frequencies, G’ becomes greater than G’’ indicating that the polymer behaves as a more 403 
elastic material [58]. The observed difference in both moduli for different HPMC grade is 404 
normal since polymers with higher molecular weight increase the entanglement density [59]. 405 
E10M had the strongest G’ and G’’ with 1.4 Pa frequency to get to gel critical point 406 
indicating that E10M is more elastic [58, 59]. There is a poor evidence of gel formation in 407 
figure 4b. Therefore E50LV system is more susceptible to erosion and/or dilution during drug 408 
release study [59]. Talukdar et al. reported no detectable influence of the ionic strength of the 409 
medium on the rheological properties of HPMC [59]. This is in good agreement with the 410 
present study, as shown in figure 5a and b. There was no significant difference (P > 0.05) in 411 
yield stress figure 5a and G’ figure 5b of the same HPMC grade samples treated with the two 412 
different ionic strength solutions (pH 1.2 media (no NaCl) and pH 1.2 media (0.4M NaCl)), 413 
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this may be due to non-ionic charge of HPMC polymer. This result thus explained the 414 
independence of drug release in different ionic strength media.  415 
 416 
3.4. DSC analysis 417 
DSC traces showed no material interaction between the drug, theophylline, and the HPMC 418 
polymers (Figure not included). DSC hydration showed the E50LV tablet matrices to 419 
generally have more bound water compared to the E4M and E10M tablet matrices 420 
(Supplementary figure 7) suggesting that it would be more prone to food effects and that the 421 
penetration of the various media into the matrix used happened more quickly [41]. All 422 
polymers showed an increase in bound water with the increase in ionic strength thus agreeing 423 
with findings for bound and free water states in K chemistry HPMC matrices [41]. As the 424 
ratio of bound water to free water increases, the amount of water available for polymer 425 
hydration is reduced thereby the gel layer for controlling drug release is somewhat 426 
compromised. Yoshioka et al.  [27] and Aoki et al. [26] showed that bound water did not 427 
contribute significantly to drug release and that water uptake by hydrophilic matrices was 428 
dependant on the amount of free water present in the system. The amount of drug released at 429 
the 10 min time point also correlated with the DSC hydration experiments as in [41]. The 430 
theophylline release increased with an increase in the ionic concentration strength. In the 431 
highest ionic concentration strength medium, the amount of bound water was similar for all 432 
the formulations tested suggesting that the strength of the gel played an important role also in 433 
the drug release pattern as also in [41]. 434 
 435 
 436 
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4. Conclusion 437 
HPMC E50LV particles were of a smaller size, smaller surface area and smoother surfaces 438 
than E4M and E10M grades of HPMC. The polymers E4M, E10M and E50LV are effective 439 
in dissipating electrostatic charge of the API. Drug release from E50LV and E4M matrices 440 
was affected by changing agitation and ionic strength. With regards to agitation, there was an 441 
increase in drug release with an increase in agitation. Ascending and descending rates of 442 
agitation were used to differentiate between all three formulations and showed the E10M 443 
tablet matrices to be more resilient to the impact of agitation. Incremental increases in ionic 444 
strength also had a profound effect on the E50LV and E4M tablet matrices. This could be 445 
attributed to the fact that an increase in the ion concentration in a polymer solution decreases 446 
the solubility or hydration of the polymer thereby reducing the amount of available water for 447 
hydrating the polymer. Rheological evaluation of the gels indicated a high degree of inter-448 
particulate interactions which can suggest a lower degree of erosion for E10M as compared to 449 
the other polymers. The E10M polymer was also resilient to the influence of ionic strength. 450 
DSC studies on the hydration states also proved useful in explaining drug release from the E-451 
chemistry HPMC polymers. This highlights the importance of choosing the right HPMC 452 
polymer for the extended release matrix.  453 
 454 
5. Acknowledgements 455 
The authors are grateful to Colorcon for the free gift of hypromellose and to the University of 456 
Huddersfield for funding this research. 457 
 458 
 459 
 460 
 461 
 462 
 
20 
References  463 
[1] F. Lotfipour, A. Nokhodchi, M. Saeedi, S. Norouzi-Sani, J. Sharbafi, M.R. Siahi-464 
Shadbad, The effect of hydrophilic and lipophilic polymers and fillers on the release rate of 465 
atenolol from HPMC matrices, Farmaco, 59 (2004) 819 466 
[2] S. Takka, S. Rajbhandari, A. Sakr, Effect of anionic polymers on the release of 467 
propranolol hydrochloride from matrix tablets, Eur. J. Pharm. Biopharm., 52 (2001) 75 468 
[3] C.G. Cameron, J.W. McGinit, Controlled-Release Theophylline Tablet Formulations 469 
Containing Acrylic Resins, II. Combination Resin Formulations, Drug Dev. Ind. Pharm., 13 470 
(1987) 1409 471 
[4] G.S. Rekhi, R.V. Nellore, A.S. Hussain, L.G. Tillman, H.J. Malinowski, L.L. Augsburger, 472 
Identification of critical formulation and processing variables for metoprolol tartrate 473 
extended-release (ER) matrix tablets, J. Control. Release, 59 (1999) 327. 474 
[5] M.A. Vandelli, E. Leo, F. Foni, M.T. Bernabei, Drug release from perforated matrices 475 
containing hydroxypropylcellulose, Int. J. Pharm., 171 (1998) 165. 476 
[6] B. Saša, P. Odon, S. Stane, K. Julijana, Analysis of surface properties of cellulose ethers 477 
and drug release from their matrix tablets, Eur. J. Pharm. Sci., 27 (2006) 375. 478 
[7] M.R. Siahi-Shadbad, K. Asare-Addo, K. Azizian, D. Hassanzadeh, A. Nokhodchi, 479 
Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium 480 
powder in combination with hydrophilic polymers, AAPS PharmSciTech, 12 (2011) 1176 481 
[8] K. Asare-Addo, A.O. Adebisi, A. Nokhodchi, Agitation Sequence and Ionic Strength on 482 
In-Vitro Drug Release from Hypromellose–The Influence of Compaction Force, Int Journal 483 
of Basic Medical Sciences and Pharmacy (IJBMSP), 5 (2015) 1 484 
[9] B. Abrahamsson, K. Roos, J. Sjogren, Investigation of prandial effects on hydrophilic 485 
matrix tablets, Drug Dev. Ind. Pharm., 25 (1999) 765 486 
[10] W. Phuapradit, S. Bolton, The influence of tablet density on the human oral absorption 487 
of sustained release acetaminophen matrix tablets, Drug Dev. Ind. Pharm., 17 (1991) 1097 488 
[11] L.E. Schmidt, K. Dalhoff, Food-drug interactions, Drugs, 62 (2002) 1481 489 
[12] J. Nekvindova, P. Anzenbacher, Interactions of food and dietary supplements with drug 490 
metabolising cytochrome P450 enzymes, Ceska Slov. Farm., 56 (2007) 165 491 
[13] R. Bushra, N. Aslam, A.Y. Khan, Food-Drug Interactions, Oman Med. J., 26 (2011)  492 
[14] N. Washington, C. Wilson, Physiological Pharmaceutics Ellis Horwood Ltd, Chichester, 493 
1989 494 
 
21 
[15] W.N. Charman, C.J. Porter, S. Mithani, J.B. Dressman, Physiochemical and 495 
physiological mechanisms for the effects of food on drug absorption: the role of lipids and 496 
pH, J. Pharm. Sci., 86 (1997) 269 497 
[16] M.C. Bonferoni, S. Rossi, F. Ferrari, M. Bertoni, C. Caramella, Influence of medium on 498 
dissolution-erosion behaviour of Na carboxymethylcellulose and on viscoelastic properties of 499 
gels, Int. J. Pharm., 117 (1995) 41 500 
[17] A.C. Hodsdon, J.R. Mitchell, M.C. Davies, C.D. Melia, Structure and behaviour in 501 
hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained-502 
release performance and internal gel structure of sodium alginate matrices, J. Control. 503 
Release, 33 (1995) 143 504 
[18] J.L. Johnson, J. Holinej, M.D. Williams, Influence of ionic strength on matrix integrity 505 
and drug release from hydroxypropyl cellulose compacts, Int. J. Pharm., 90 (1993) 151 506 
[19] A. Nokhodchi, S. Raja, P. Patel, K. Asare-Addo, The role of oral controlled release 507 
matrix tablets in drug delivery systems, BioImpacts : BI, 2 (2012) 175 508 
[20] A. Nokhodchi, K. Asare-Addo, Drug release from matrix tablets: physiological 509 
parameters and the effect of food, Expert Opin Drug Deliv, 11 (2014) 1401 510 
[21] B. Abrahamsson, D. Johansson, A. Torstensson, K. Wingstrand, Evaluation of 511 
solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of 512 
felodipine, Pharm. Res., 11 (1994) 1093 513 
[22] J.W. Skoug, M.V. Mikelsons, C.N. Vigneron, N.L. Stemm, Qualitative evaluation of the 514 
mechanism of release of matrix sustained release dosage forms by measurement of polymer 515 
release, J. Control. Release, 27 (1993) 227 516 
[23] W.D. Lindner, B.C. Lippold, Drug release from hydrocolloid embeddings with high or 517 
low susceptibility to hydrodynamic stress, Pharm. Res., 12 (1995) 1781 518 
[24] A. Nokhodchi, D. Palmer, K. Asare-Addo, M. Levina, A. Rajabi-Siahboomi, 519 
Application of Polymer Combinations in Extended Release Hydrophilic Matrices, in:  520 
Handbook of Polymers for Pharmaceutical Technologies, John Wiley & Sons, Inc., 2015, pp. 521 
23 522 
[25] C.B. McCrystal, J.L. Ford, A.R. Rajabi-Siahboomi, A study on the interaction of water 523 
and cellulose ethers using differential scanning calorimetry, Thermochimica Acta, 294 (1997) 524 
91 525 
[26] S. Aoki, H. Ando, M. Ishii, S. Watanabe, H. Ozawa, Water behavior during drug release 526 
from a matrix as observed using differential scanning calorimetry, J. Control. Release, 33 527 
(1995) 365 528 
[27] S. Yoshioka, Y. Aso, T. Terao, Effect of water mobility on drug hydrolysis rates in 529 
gelatin gels, Pharm. Res., 9 (1992) 607 530 
 
22 
[28] S. Baumgartner, G. Lahajnar, A. Sepe, J. Kristl, Investigation of the state and dynamics 531 
of water in hydrogels of cellulose ethers by(1)H NMR spectroscopy, AAPS PharmSciTech, 3 532 
(2002) 86 533 
[29] M.S. Jhon, J.D. Andrade, Water and hydrogels, J. Biomed. Mater. Res., 7 (1973) 509 534 
[30] B.H. Kaye, Powder Mixing, 1 ed., Chapman & Hall, London, UK 1997. 535 
[31] J. Staniforth, J. Rees, Powder mixing by triboelectrification, Powder Tech 30 (1981) 255 536 
[32] K. Asare-Addo, W. Kaialy, M. Levina, A. Rajabi-Siahboomi, M.U. Ghori, E. Supuk, 537 
P.R. Laity, B.R. Conway, A. Nokhodchi, The influence of agitation sequence and ionic 538 
strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of 539 
the USP III apparatus, Colloids Surf B Biointerfaces, 104 (2013) 54 540 
[33] U.S.P. Convention, The United States Pharmacopoeia USP 26-the National Formulary 541 
NF21: By Authority of the United States Pharmacopeial Convention, Inc., Meeting at 542 
Washington, D.C., April 12-16, 2000, United States Pharmacopeial Convention, 2003. 543 
[34] E. Šupuk, C. Seiler, M. Ghadiri, Analysis of a Simple Test Device for Tribo-Electric 544 
Charging of Bulk Powders, Particle & Particle Systems Characterization, 26 (2009) 7 545 
[35] E. Supuk, M.U. Ghori, K. Asare-Addo, P.R. Laity, P.M. Panchmatia, B.R. Conway, The 546 
influence of salt formation on electrostatic and compression properties of flurbiprofen salts, 547 
Int. J. Pharm., 458 (2013) 118 548 
[36] K. Asare-Addo, E. Supuk, H. Al-Hamidi, S. Owusu-Ware, A. Nokhodchi, B.R. Conway, 549 
Triboelectrification and dissolution property enhancements of solid dispersions, Int. J. 550 
Pharm., 485 (2015) 306 551 
[37] W. Kaialy, T. Hussain, A. Alhalaweh, A. Nokhodchi, Towards a More Desirable Dry 552 
Powder Inhaler Formulation: Large Spray-Dried Mannitol Microspheres Outperform Small 553 
Microspheres, Pharm. Res., 31 (2014) 60 554 
[38] K. Asare-Addo, M. Levina, A.R. Rajabi-Siahboomi, A. Nokhodchi, Study of dissolution 555 
hydrodynamic conditions versus drug release from hypromellose matrices: the influence of 556 
agitation sequence, Colloids Surf B Biointerfaces, 81 (2010) 452. 557 
[39] X. Mu, M.J. Tobyn, J.N. Staniforth, Influence of physiological variables on the in vitro 558 
drug-release behavior of a polysaccharide matrix controlled-release system, Drug Dev. Ind. 559 
Pharm., 29 (2003) 19. 560 
[40] K. Mitchell, J.L. Ford, D.J. Armstrong, P.N.C. Elliott, C. Rostron, J.E. Hogan, The 561 
influence of additives on the cloud point, disintegration and dissolution of 562 
hydroxypropylmethylcellulose gels and matrix tablets, Int. J. Pharm., 66 (1990) 233. 563 
[41] K. Asare-Addo, M. Levina, A.R. Rajabi-Siahboomi, A. Nokhodchi, Effect of ionic 564 
strength and pH of dissolution media on theophylline release from hypromellose matrix 565 
 
23 
tablets—Apparatus USP III, simulated fasted and fed conditions, Carbohydrate Polymers, 86 566 
(2011) 85. 567 
[42] J.W. Moore, H.H. Flanner, Mathematical comparison of dissolution profiles Pharma 568 
Tech 20 (1996) 64 569 
[43] J.E. Polli, G.S. Rekhi, L.L. Augsburger, V.P. Shah, Methods to compare dissolution 570 
profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets, J. 571 
Pharm. Sci., 86 (1997) 690. 572 
[44] K.A. Khan, The concept of dissolution efficiency, J. Pharm. Pharmacol., 27 (1975) 48. 573 
[45] H. Al-Hamidi, A.A. Edwards, D. Douroumis, K. Asare-Addo, A.M. Nayebi, S. Reyhani-574 
Rad, J. Mahmoudi, A. Nokhodchi, Effect of glucosamine HCl on dissolution and solid state 575 
behaviours of piroxicam upon milling, Colloids Surf B Biointerfaces, 103 (2013) 189. 576 
[46] J. Siepmann, N. Peppas, Mathematical modeling of controlled drug delivery, Adv Drug 577 
Del Rev, 48 (2001) 137. 578 
[47] W. Kaialy, P. Emami, K. Asare-Addo, S. Shojaee, A. Nokhodchi, Psyllium: a promising 579 
polymer for sustained release formulations in combination with HPMC polymers, Pharm. 580 
Dev. Technol., 19 (2014) 269. 581 
[48] E. Šupuk, A. Zarrebini, J.P. Reddy, H. Hughes, M.M. Leane, M.J. Tobyn, P. Timmins, 582 
M. Ghadiri, Tribo-electrification of active pharmaceutical ingredients and excipients, Powder 583 
Tech, 217 (2012) 427. 584 
[49] D. J. Lacks and A. Levandovsky, Effect of particle size distribution on the polarity of 585 
triboelectric charging in granular insulator systems, J Electrostat, 65 (2007) 107–112. 586 
[50] W. Kaialy, A review of factors affecting electrostatic charging of pharmaceuticals and 587 
adhesive mixtures for inhalation, Int J Pharm. (2016) In press. doi: 588 
10.1016/j.ijpharm.2016.01.076 589 
[51] A. O. Adebisi, W. Kaialy, T. Hussain, H. Al-Hamidi, A. Nokhodchi, B. R. Conway, K. 590 
Asare-Addo, An assessment of triboelectrification effects on co-ground solid dispersions of 591 
carbamazepine, Powder Tech, 292, (2016). 342. 592 
[52] K. Asare-Addo, B.R. Conway, H. Larhrib, M. Levina, A.R. Rajabi-Siahboomi, J. Tetteh, 593 
J. Boateng, A. Nokhodchi, The effect of pH and ionic strength of dissolution media on in-594 
vitro release of two model drugs of different solubilities from HPMC matrices, Colloids Surf 595 
B Biointerfaces, 111 (2013) 384. 596 
[53] N. Kavanagh, O.I. Corrigan, Swelling and erosion properties of 597 
hydroxypropylmethylcellulose (Hypromellose) matrices - Influence of agitation rate and 598 
dissolution medium composition, Int J Pharm, 279 (2004), 141 599 
 
24 
[54] D.A. Alderman, A review of cellulose ethers in hydrophilic matrices for oral controlled-600 
release dosage forms, International Journal of Pharmaceutical Technology and Product 601 
Manufacture, 5 (1984), 1 602 
[55] M.H. Mahdi, B.R. Conway, A.M. Smith, Development of mucoadhesive sprayable 603 
gellan gum fluid gels, Int. J. Pharm., 488 (2015) 12. 604 
[56] I. Fernández Farrés, I.T. Norton, The influence of co-solutes on tribology of agar fluid 605 
gels, Food Hydrocolloids, 45 (2015) 186. 606 
[57] M.H. Mahdi, B.R. Conway, A.M. Smith, Evaluation of gellan gum fluid gels as 607 
modified release oral liquids, Int. J. Pharm., 475 (2014) 335. 608 
[58] T. Hoare, D. Zurakowski, R. Langer, D.S. Kohane, Rheological blends for drug delivery. 609 
I. Characterization in vitro, Journal of biomedical materials research. Part A, 92 (2010) 575. 610 
[59] M.M. Talukdar, I. Vinckier, P. Moldenaers, R. Kinget, Rheological characterization of 611 
xanthan gum and hydroxypropylmethyl cellulose with respect to controlled-release drug 612 
delivery, J. Pharm. Sci., 85 (1996) 537. 613 
 614 
 615 
 616 
 617 
 618 
 619 
 620 
 621 
 622 
 623 
 624 
 625 
 626 
 627 
 628 
 629 
 
25 
Table 1: Tribo-electric properties of HPMC polymers, theophylline and their powder blends 630 
and Volume mean diameter (VMD), span, BET surface area, roughness, true density and 631 
water content, for E4M, E10M and E50LV HPMC polymers (SD, n=3) 632 
Powders and 
Blends 
Charge Adhesion 
VMD  Span 
BET surface 
area  Roughness True density  
Water 
content   
Qsat (nC/g) *Adh (%)  (µm) 
 
(m2/g) 
 
(g/cm3)  (%) 
Theophylline -23.1 + 0.8 15.0 + 2.3 - - - - - - 
E4M 26.9 + 5.38 17.9 + 2.0 81.9 ± 0.3 1.4 ± 0.0 0.26 ± 0.02 1.30 ± 0.11 1.35 ± 0.01 3.7 
E10M -5.2 + 1.0 12.1 + 0.6 77.3 ± 0.5 1.6 ± 0.0 0.24 ± 0.02 1.12 ± 0.07 1.37 ± 0.01 3.4 
E50LV -1.5 + 0.4 9.9 + 1.3 72.7 ± 0.2 1.7 ± 0.0 0.14 ± 0.02 0.72 ± 0.13 1.36 ± 0.01 3.7 
E4M Blend -4.0 + 0.2 15.9 + 0.2 - - - - - - 
E10M Blend -5.0 + 0.7 16.4 + 1.3 - - - - - - 
E50LV Blend -5.1 + 0.2 16.6 + 0.6 - - - - - - 
 633 
*Adh is the powder particles adhered to the walls of the shaking container. 634 
 635 
 636 
 637 
 638 
 639 
 640 
 641 
 642 
 643 
 644 
 645 
 646 
 647 
 648 
 649 
 650 
 651 
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Table 2:  Effect of agitation rate on similarity factor (f2) and mechanism of drug release for 652 
formulated tablets 653 
Tablet Formulation Agitation RSQ n f2 
E50LV 5 0.9856 0.5816 51 
E50LV 10 0.9742 0.5892 n/a 
E50LV 15 0.9894 0.6659 - 
E50LV 20 0.9909 0.557 - 
E50LV 30 0.9883 0.6036 - 
E50LV 5-30 0.9937 0.7484 52 
E50LV 30-5 0.9877 0.5855 - 
E4M 5 0.9873 0.4001 44 
E4M 10 0.9913 0.2779 n/a 
E4M 15 0.9803 0.2353 - 
E4M 20 0.9888 0.2387 55 
E4M 30 0.9835 0.2148 - 
E4M 5-30 0.9977 0.503 31 
E4M 30-5 0.9834 0.2027 - 
E10M 5 0.9929 0.3794 54 
E10M 10 0.9939 0.324 n/a 
E10M 15 0.9945 0.2601 50 
E10M 20 0.9922 0.2854 48 
E10M 30 0.9922 0.2507 36 
E10M 5-30 0.9971 0.465 60 
E10M 30-5 0.9764 0.2235 34 
 654 
Note:  n/a as release profile at 10 dpm used as reference 655 
 656 
 657 
 658 
 659 
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Table 3: Similarity factor (f2) and release parameters for tablet matrices 660 
   
Drug-release characteristics  
Tablet 
Formulation 
Ionic 
strengths 
Agitation 
 (dpm) 
DE310min 
(%) 
MDT  
(min) 
MDR 
(%min
-1
) 
RSQ  
(r
2
) n 
f2 
E50LV 
 
Water (0) 20 85.72 39.43 0.28 0.9886 0.6733 n/a 
(no salt) 20 85.62 36.48 0.26 0.9909 0.5570 - 
(+0.2 M salt) 20 87.46 29.04 0.20 0.9941 0.3705 - 
(+0.4 M salt) 20 89.79 23.06 0.16 0.9900 0.2515 - 
E4M 
 
Water (0) 20 81.58 21.18 0.14 0.9935 0.2686 n/a 
(no salt) 20 79.40 21.44 0.14 0.9888 0.2387 95 
(+0.2 M salt) 20 91.59 16.97 0.11 0.9577 0.1388 - 
 (+0.4 M salt) 20 91.44 15.09 0.09 0.9786 0.1245 - 
E10M 
 
Water (0) 20 65.59 23.05 0.13 0.9927 0.3121 n/a 
(no salt) 20 66.55 22.65 0.13 0.9922 0.2854 82 
(+0.2 M salt) 20 68.36 20.16 0.11 0.9949 0.2387 63 
 (+0.4 M salt) 20 77.35 16.84 0.11 0.9848 0.2677 50 
 661 
Note:  n/a as release profile at 20 dpm in water was used as reference 662 
 663 
 664 
 665 
 666 
 667 
 668 
 669 
 670 
 671 
 672 
 673 
 674 
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Figure captions  675 
Figure 1 - The effect of rate and order of agitation on drug release from HPMC (a) E50LV 676 
tablet matrix formulations (SD, n=3) (b) Drug release rates of the E chemistry tablet 677 
formulations with respect to the differing agitations. Standard deviations were smaller than 678 
the symbol size and as such were not shown here. 679 
Note:  680 
Ascending order of agitation is depicted as 5 - 30 dpm and is when agitation was increased by 681 
5 dpm every time the cylinder containing the drug moved from one vial to the other. Thus, in 682 
pH 1.2 agitation was 5 dpm, in pH 2.2 - 10 dpm, in pH 5.8 - 15 dpm, in pH 6.8 - 20 dpm, in 683 
pH 7.2 - 25 dpm and in pH 7.5 - 30 dpm.  684 
Descending order of agitation is depicted as 30 - 5 dpm and is when agitation was decreased 685 
by 5 dpm every time the cylinder containing the drug moved from one vial to the other. Thus, 686 
in pH 1.2 agitation was 30 dpm, in pH 2.2 - 25 dpm, in pH 5.8 - 20 dpm, in pH 6.8 - 15 dpm, 687 
in pH 7.2 - 10 dpm and in pH 7.5 - 5 dpm [20] 688 
Figure 2 - The amount of drug released (%) from HPMC (a) E50LV (b) E10M tablet matrix 689 
formulations when increasing the agitation rate during the dissolution test (SD, n=3).  690 
Note:  691 
*Ascending order of agitation; agitation was increased by 5 dpm every time the cylinder 692 
containing the drug moved from one vial to the other. Thus, in pH 1.2 agitation was 5 dpm, in 693 
pH 2.2 - 10 dpm, in pH 5.8 - 15 dpm, in pH 6.8 - 20 dpm, in pH 7.2 - 25 dpm and in pH 7.5 - 694 
30 dpm. 695 
 **Descending order of agitation; agitation was decreased by 5 dpm every time the cylinder 696 
containing the drug moved from one vial to the other. Thus, in pH 1.2 agitation was 30 dpm, 697 
in pH 2.2 - 25 dpm, in pH 5.8 - 20 dpm, in pH 6.8 - 15 dpm, in pH 7.2 - 10 dpm and in pH 698 
7.5 - 5 dpm [20]. 699 
Figure 3 -The effect of ionic strength on drug release from HPMC (a) E50LV tablet matrix 700 
formulations (b) Amount of drug released from E chemistry HPMC tablet matrices 701 
formulations after 1 hour in media of varying ionic strengths (SD, n=3) 702 
Figure 4 -  Stress sweep for at 1.5 HZ for 5% HPMC as a function of different HPMC grade, 703 
E10M, E4M and E50LV (a) Elastic (G’ unfilled symbols) and viscous (G’’ filled symbols) 704 
moduli as a function of frequency for E50LV (circle symbols) (b)  705 
Figure 5 - Yield stress measurement at 37 °C for E50LV, E4M and E10M, dispersed in 706 
different ionic strength medium (a) Elastic modulus measurement at 37 °C for E50LV, E4M 707 
and E10M dispersed in different ionic strength medium (b) (SD, n=3).   708 
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Figure 2  734 
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Figure 5 786 
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Supplementary material 806 
 807 
Supplementary figure 1 - SEM images for E4M, E10M and E50LV E chemistry HPMC 808 
polymers 809 
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Supplementary figure 2 - The effect of rate and order of agitation on drug release from 825 
HPMC (a) E4M (b) E10M tablet matrix formulations 826 
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 845 
Supplementary figure 3 - The amount of drug released (%) from HPMC E4M tablet matrix 846 
formulations when increasing the agitation rate during the dissolution test.  847 
Note:  848 
*Ascending order of agitation; agitation was increased by 5 dpm every time the cylinder containing the drug 849 
moved from one vial to the other. Thus, in pH 1.2 agitation was 5 dpm, in pH 2.2 - 10 dpm, in pH 5.8 - 15 dpm, 850 
in pH 6.8 - 20 dpm, in pH 7.2 - 25 dpm and in pH 7.5 - 30 dpm. 851 
 **Descending order of agitation; agitation was decreased by 5 dpm every time the cylinder containing the drug 852 
moved from one vial to the other. Thus, in pH 1.2 agitation was 30 dpm, in pH 2.2 - 25 dpm, in pH 5.8 - 20 853 
dpm, in pH 6.8 - 15 dpm, in pH 7.2 - 10 dpm and in pH 7.5 - 5 dpm [20]. 854 
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 866 
Supplementary figure 4 - The effect of ionic strength on drug release from HPMC (a) E4M 867 
(b) E10M tablet matrix formulations  868 
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Supplementary figure 5 - Drug release rates of the E chemistry tablet formulations with 889 
respect to the differing ionic strengths  890 
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 906 
Supplementary figure 6 - Elastic (G’ unfilled symbols) and viscous (G’’ filled symbols) 907 
moduli as a function of frequency for (a), E4M (triangle symbols) (b), E10M (square 908 
symbols)  909 
 910 
 911 
 912 
 913 
 914 
 915 
 916 
 917 
 918 
 919 
 920 
 921 
 922 
 923 
 924 
(a) (b)
 
40 
 925 
Supplementary figure 7 - Amount of bound water for the different E chemistry HPMC 926 
grade formulations resulting from 10 min hydration in relevant media of varying ionic 927 
strengths 928 
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